Trump Executive Order Restricts Federal Funding for Youth Gender-Affirming Care
The directive halts U.S. government support for gender-transition procedures for minors, sparking widespread debate and legal challenges.
- President Trump's executive order prohibits federal funding for gender-affirming care for individuals under 19, including hormone therapy and puberty blockers.
- The order has led some medical institutions to pause youth treatments, creating confusion and distress for patients, families, and healthcare providers.
- Proponents argue the move protects minors from irreversible medical interventions, while critics highlight its potential harm to mental health and suicide prevention efforts.
- Medical professionals and advocacy groups have filed lawsuits challenging the order, claiming it discriminates against transgender youth and violates constitutional rights.
- The executive order has intensified debates over the role of federal policy in healthcare, with implications for religious liberty and LGBTQ+ rights.